Lactic dehydrogenase and cancer: an overview. Front Biosci (Landmark Ed). 2015 Jun 01;20(8):1234-49. \[[PubMed: 25961554](https://pubmed.ncbi.nlm.nih.gov/25961554)\] 27. Liu J, Chen G, Liu Z, Liu S, Cai Z, You P, Ke Y, Lai L, Huang Y, Gao H, Zhao L, Pelicano H, Huang P, McKeehan WL, Wu CL, Wang C, Zhong W, Wang F. Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer. Cancer Res. 2018 Aug 15;78(16):4459-4470. \[[PMC free article: PMC6095720](/pmc/articles/PMC6095720/)\] \[[PubMed: 29891507](https://pubmed.ncbi.nlm.nih.gov/29891507)\] 28. Granchi C, Bertini S, Macchia M, Minutolo F. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials. Curr Med Chem. 2010;17(7):672-97. \[[PubMed: 20088761](https://pubmed.ncbi.nlm.nih.gov/20088761)\] 29. Di Bussolo V, Calvaresi EC, Granchi C, Del Bino L, Frau I, Lang MC, Tuccinardi T, Macchia M, Martinelli A, Hergenrother PJ, Minutolo F. Synthesis and biological evaluation of non-glucose glycoconjugated _N_ -hydroyxindole class LDH inhibitors as anticancer agents. RSC Adv. 2015;5(26):19944-19954. \[[PMC free article: PMC4497792](/pmc/articles/PMC4497792/)\] \[[PubMed: 26167277](https://pubmed.ncbi.nlm.nih.gov/26167277)\] 30. Urbańska K, Orzechowski A. Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells. Int J Mol Sci. 2019 Apr 27;20(9) \[[PMC free article: PMC6539221](/pmc/articles/PMC6539221/)\] \[[PubMed: 31035592](https://pubmed.ncbi.nlm.nih.gov/31035592)\] 31. Augoff K, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2015 Mar 01;358(1):1-7. \[[PubMed: 25528630](https://pubmed.ncbi.nlm.nih.gov/25528630)\] 32. Martens A, Wistuba-Hamprecht K, Geukes Foppen M, Yuan J, Postow MA, Wong P, Romano E, Khammari A, Dreno B, Capone M, Ascierto PA, Di Giacomo AM, Maio M, Schilling B, Sucker A, Schadendorf D, Hassel JC, Eigentler TK, Martus P, Wolchok JD, Blank C, Pawelec G, Garbe C, Weide B. Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab. Clin Cancer Res. 2016 Jun 15;22(12):2908-18. \[[PMC free article: PMC5770142](/pmc/articles/PMC5770142/)\] \[[PubMed: 26787752](https://pubmed.ncbi.nlm.nih.gov/26787752)\] 33. Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, Kähler K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier F, Martus P, Maio M, Blank C, Schadendorf D, Dummer R, Ascierto PA, Hospers G, Garbe C, Wolchok JD. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab. Clin Cancer Res. 2016 Nov 15;22(22):5487-5496. \[[PMC free article: PMC5572569](/pmc/articles/PMC5572569/)\] \[[PubMed: 27185375](https://pubmed.ncbi.nlm.nih.gov/27185375)\] 34. Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG., Oblimersen Melanoma Study